Oculo‐palato‐cerebral syndrome: A third case supporting autosomal recessive inheritance

Abstract

In 1985, Frydman et al. [1985: Clin Genet 27:414-419] described a syndrome characterized by growth failure, microcephaly, persistent hyperplastic primary vitreous (PHPV) with microphthalmia, cleft palate, connective tissue abnormality, mental retardation, and spastic quadriplegia. The syndrome was termed as oculo-palato-cerebral dwarfism. The first patients described were offsprings of a consanguineous couple of Moroccan Jewish descent, suggesting autosomal recessive inheritance. An additional case was reported by Pellegrino et al. [2001: Am J Med Genet 99:200-203] in 2001. The clinical features were milder than the original cases, and there was no consanguinity. We report a third patient with oculo-palato-cerebral syndrome, supporting autosomal recessive inheritance, and a detailed comparison with the previous cases. This article contains supplementary material, which may be viewed at the American Journal of Medical Genetics website at http://www.interscience.wiley.com/jpages/0148-7299/suppmat/index.html.

Cell cycle regulation therapy combined with cytokine blockade enhances antiarthritic effects without increasing immune suppression

“…Palbociclib (formerly called PD0332991) is a highly selective CDK4/6 inhibitor (CDKI) under development as an anticancer agent 17. Although its monotherapy was not effective in clinical trials, combination therapy with letrozole extended progression-free survival of patients with advanced breast cancer over threefold compared with letrozole monotherapy 18.…”